Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
05/09/2016
|
SPPI |
|
PDUFA |
Oncology |
Orphan Drug |
|
05/11/2016
|
AAAP |
|
Phase 3 Results |
Oncology |
Orphan Drug, Priority Review |
|
06/01/2016
|
AAAP |
|
PDUFA |
Oncology |
None, Orphan Drug, Priority Review |
|
10/22/2016
|
OPK |
|
PDUFA |
Endocrine |
None |
|
Q3 2016
|
ACRS |
|
Phase 2 Results |
Other |
None |
|
Q3 2016
|
AERI |
|
Phase 3 Results |
Opthamology |
None |
|
H2 2016
|
GWPH |
|
Phase 3 Results |
Neurology |
Fast Track, Orphan Drug |
|
07/19/2016
|
VRX |
|
PDUFA |
Other |
None |
|
07/01/2016
|
INSY |
|
PDUFA |
Oncology |
None |
|
Q2 2016
|
PRTK |
|
Phase 3 Results |
Infectious Disease |
Fast Track |
|